Your browser doesn't support javascript.
loading
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.
Schmitt, Christophe; Brockwell, Laura; Giraudon, Mylène; Zucchetto, Mauro; Christ, Lisa; Bannert, Bettina; Daikeler, Thomas; Villiger, Peter M.
Affiliation
  • Schmitt C; Department of Clinical Pharmacology, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070, Basel, Switzerland. christophe.schmitt@roche.com.
  • Brockwell L; F. Hoffmann-La Roche Ltd, Welwyn Garden City, UK.
  • Giraudon M; Department of Clinical Pharmacology, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070, Basel, Switzerland.
  • Zucchetto M; Paraxel International, Milan, Italy.
  • Christ L; Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, Bern, Switzerland.
  • Bannert B; Department of Rheumatology, USB - University Hospital Basel, Basel, Switzerland.
  • Daikeler T; Department of Rheumatology, USB - University Hospital Basel, Basel, Switzerland.
  • Villiger PM; Medical Center Monbijou, Bern, Switzerland.
Arthritis Res Ther ; 24(1): 133, 2022 06 04.
Article in En | MEDLINE | ID: mdl-35659282
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Giant Cell Arteritis Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Giant Cell Arteritis Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2022 Document type: Article Affiliation country: